News

Press Releases | Mar. 18, 2025

Norstella named to Fast Company’s annual list of the world’s most innovative companies of 2025

New York – March 18, 2025 – Norstella, a leading global provider of pharma intelligence solutions, is proud to have been named to Fast Company’s prestigious list of the World’s Most Innovative Companies of 2025. This year’s list shines a spotlight on businesses that are shaping industry and culture through their innovations to set new standards and achieve remarkable milestones in all sectors of the economy. Read more

Press Releases | Feb. 05, 2025

Neelesh Sali named Managing Director & Country Head of Norstella India

New York – February 5, 2025 – Norstella, a leading global provider of pharma intelligence solutions, is proud to announce the appointment of Neelesh Sali as Managing Director and Country Head for India. With over 30 years of leadership experience driving operational excellence and scaling global organizations, Neelesh brings a proven track record of transformative growth and innovation to Norstella’s mission of smoothing the path to life-saving treatments. Read more

Press Releases | Feb. 04, 2025

NorstellaLinQ data source added to Atropos Evidence™ Network, scoring in the top decile for data quality on Real World Fitness Score®

Palo Alto, CA – February 4, 2025 – Atropos Health, the pioneer in translating real-world clinical data into high-quality personalized real-world evidence (RWE) for care, announces the availability of an initial dataset from NorstellaLinQ on the Atropos Evidence Network. NorstellaLinQ, built by Norstella, one of the largest global pharma intelligence solution providers, is the first and only fully integrated data asset combining real-world data (RWD) and proprietary intelligence from the most trusted brands in the industry, paving the way for breakthroughs in drug development and commercialization. Read more

In the news | Jan. 16, 2025

NorstellaLinQ in the news

Since introducing NorstellaLinQ, biopharma’s first fully integrated data asset combining RWD and our wealth of proprietary information, we have been busily meeting with customers to explain how it can support their workflows. It is not only our pharma partners that have taken notice, but the trade media has also wanted to learn more. Suzanne Caruso, General Manager for Clinical & Regulatory at Norstella, met with reporters from STAT and Precision Medicine Online to explain. Read more

In the news | Nov. 20, 2024

Norstella recognized as company of the year in the 2024 BIG Awards for Business

Norstella is pleased to announce that the Business Intelligence Group has selected the company as a winner in its hotly contested "Company of the Year" category. This recognition, part of the broader 2024 BIG Awards for Business, celebrates those companies, products, and leaders making a significant impact by reshaping their industries and setting new standards for success. For Norstella, it signifies the considerable progress we are making against our mission to to smooth the path to lifesaving therapies for patients and providers. Read more

Press Releases | Oct. 08, 2024

Norstella introduces NorstellaLinQ, the biopharma industry’s first fully integrated data asset

NEW YORK – October 8, 2024 - Today, Norstella unveiled NorstellaLinQ, the biopharma industry’s first and only fully integrated data asset combining both real-world data (RWD) — including open and closed claims, lab results and structured and unstructured electronic medical records (EMR) — with Norstella’s proprietary forecasting, clinical, regulatory, payer, coverage and commercial intelligence data. Read more

Press Releases | Sep. 05, 2024

Panalgo introduces IHD Cloud, a transformative solution for RWE data and analytics centralization

Boston, MA - Sept. 5, 2024 - Panalgo, a Norstella company committed to revolutionizing healthcare data analytics, is announcing the launch of IHD Cloud, a cutting-edge solution that will transform how organizations manage and use real-world data (RWD) to generate real-world evidence (RWE). Powered by Amazon Web Services (AWS), IHD Cloud offers a scalable and flexible platform to centralize data and technology, driving meaningful and timely insights for any evidence generating organization. Read more

Press Releases | Aug. 13, 2024

In a first for pharma, Citeline SmartSolutions take AI to new levels, optimizing clinical trial planning and site selection

NEW YORK – Aug. 13, 2024 – Citeline, a leader in intelligence solutions for the life sciences industry, has launched two new products — Protocol SmartDesign and Investigator SmartSelect — in its Citeline SmartSolutions suite accelerating the path from pipeline to patient. Citeline SmartSolutions, an industry first, enables users to design and conduct more predictable trials by connecting the robust data assets already trusted by over 3,000 Citeline customers. Read more

Press Releases | Jun. 17, 2024

Atropos Health partners with Norstella to expand the Atropos Evidence™ Network and structured clinical trial intelligence

BOSTON – June 17, 2024 – Norstella, one of the largest global pharma intelligence solution providers, today announced a strategic partnership with Atropos Health, the pioneer in translating real-world clinical data into high-quality personalized real-world evidence for care. This collaboration follows Atropos Health’s recent announcement of $33 million in Series B funding, furthering its expansion into life sciences. Read more

Press Releases | Jan. 10, 2024

Evaluate, a Norstella company, announces acquisition of J+D Forecasting

January 8, 2024, London, UK and Boston, MA – Evaluate, a Norstella company, announced today the acquisition of J+D Forecasting, a leading provider of forecasting solutions for the pharmaceutical industry. Read more

Press Releases | Dec. 04, 2023

MMIT wins Titan Health Award for healthcare innovation

December 4, 2023, Yardley, PA – MMIT, a Norstella company and the trusted go-to-market partner for overcoming barriers to patient access, is excited to announce that its Patient Access Analytics solution has won a Titan Health Award, which celebrates and recognizes extraordinary achievements in healthcare advertising and marketing. Read more

Press Releases | May. 16, 2023

Industry veteran Fred Hassan joins the board of Norstella

Norstella, a leader in helping patients gain access to life-saving therapies by navigating the complexities at each step of the drug development life cycle, is pleased to announce that Fred Hassan has joined its board of directors. Hassan brings a wealth of experience and expertise in healthcare, having served as CEO of several major pharmaceutical companies and as a board member of numerous healthcare organizations. He has held senior leadership roles at some of the world's most prominent organizations, including Schering-Plough, Pharmacia Corporation, and Bausch & Lomb. Read more

See More News

Norstella News